ArticlePloS one2021

CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression.

Malinee Thanee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.